The Effect of Levetiracetam on the Postmastectomy Pain Syndrome

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

September 30, 2006

Conditions
Postoperative Pain
Interventions
DRUG

Levetiracetam (drug)

The starting dose of levetiracetam was 500 mg/day and the dose was increased with 500 mg every other day to 6 tablets of 500 mg (Keppra, UCB, Belgium), divided into two doses daily corresponding to 3000 mg/day. The dose was kept at this level throughout the remaining treatment period - 4 weeks total. Six placebo tablets with identical appearance were dosed similarly to levetiracetam in the placebo phase.

Trial Locations (1)

5000

Department of neurology, Odense Universityhospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00262262 - The Effect of Levetiracetam on the Postmastectomy Pain Syndrome | Biotech Hunter | Biotech Hunter